All In Biotech

Drug Trial Radar · NCT06604442

Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men With Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy

Last checked: Nov 20, 2026Latest source record: Jul 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

62

Actual

Start

Dec 4, 2024

Primary completion

Aug 29, 2025

Study completion Aug 29, 2025

Sponsor

Lead sponsor
Blue Earth DiagnosticsIndustry
Sponsor type
Industry
Collaborators
Aixial Group
First posted
Sep 19, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
FDA-regulated drug
Yes
Who can join
Male only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men with Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy

Conditions

  • Prostate Cancer

Interventions

  • flotufolastat (18F)Drug

    Positron emission tomography (PET)

  • piflufolastat (18F)Drug

    Positron emission tomography (PET)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To Compare Urinary Bladder Radioactivity Observed on Piflufolastat (18F) PET and Flotufolastat (18F) PET.Time frame: piflufolastat (18F) administration and PET on Day 1; and flotufolastat (18F) administration and PET at least 24 hours after the piflufolastat (18F) scan but within 10 calendar days

Locations

9 sites in 1 country. Site status is shown where the registry gives one.

  • Mayo Clinic

    Phoenix, Arizona

  • City of Hope Medical Center

    Duarte, California

  • Tower Urology

    Los Angeles, California

  • Mayo Clinic

    Jacksonville, Florida

  • Endeavor Health- Glenbrook Hospital

    Glenview, Illinois

  • XCancer Omaha/Urology Cancer Center

    Omaha, Nebraska

  • Montefiore Medical Center

    The Bronx, New York

  • Cleveland Clinic

    Cleveland, Ohio

  • Urology San Antonio

    San Antonio, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.